Main Menu Map Glossary Tools Search Help AVIS Return to AleffGroup website

Tools

Diagrams

Two doses of A22 vaccine stimulate sufficient antibody against heterologous A Sau 23/86 to confer greater than 85% protection

Adapted from Schermbrucker


© Copyright 2002, AVIS Consortium. All Rights Reserved.